Expression of Tumor-Derived Vascular Endothelial Growth Factor and Its Receptors Is Associated With Outcome in Early Squamous Cell Carcinoma of the Lung

PURPOSE: Antiangiogenic therapies targeting the vascular endothelial growth factor (VEGF) pathway have yielded more modest clinical benefit to patients with non–small-cell lung cancer (NSCLC) than initially expected. Clinical data suggest a distinct biologic role of the VEGF pathway in the different...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Pajares, María J., Agorreta, Jackeline, Larrayoz, Marta, Vesin, Aurélien, Ezponda, Teresa, Zudaire, Isabel, Torre, Wenceslao, Lozano, María D., Brambilla, Elisabeth, Brambilla, Christian, Wistuba, Ignacio I., Behrens, Carmen, Timsit, Jean-Francois, Pio, Ruben, Field, John K., Montuenga, Luis M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4874209/
https://ncbi.nlm.nih.gov/pubmed/22355056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.4231
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados